HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price traded up 0.6% during trading on Wednesday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Performance
The stock has a 50 day moving average price of $25.31 and a two-hundred day moving average price of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
See Also
- Five stocks we like better than HemaCare
- How Technical Indicators Can Help You Find Oversold Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is the Dow Jones Industrial Average (DJIA)?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
